OpenVSafe by OpenVAERS
Search V-safe

7HF-37023-37183

3 vaccinations 1 coded response 10 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
121 / NY
Registered
2021-03-21
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-21
    Registered in v-safe
  2. 2021-03-21
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-21
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-11
    Dose 2 — Pfizer-BioNTech
  8. 2021-04-11
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  9. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  10. 2021-10-28
    Dose 3 — Pfizer-BioNTech
  11. 2021-10-28
    Health check-in — day 0, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  12. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-10-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2022-04-28
    Survey response — 6 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-04-28
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  16. 2022-04-29

Vaccinations

DoseDateManufacturerCo-administered
12021-03-21Pfizer-BioNTech
22021-04-11Pfizer-BioNTech
32021-10-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-04-28 Unsuccessful

Free text

Release 11 — 6 months, dose 3

2022-04-28

Symptoms: COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release